BioProcess International 2025
Hynes Convention Center, Boston, Massachusetts
September 15, 2025 - September 18, 2025BioProcess International showcases next-generation platforms and processes for the development, scale-up, and manufacture of biotherapeutics. ATCC will be showcasing our solutions that support the various phases of bioprocessing at the conference this year. Join us at booth #1615 to chat with our experts and to learn about our newest products for quality and safety testing, biologics production, cell and gene therapy development, vaccine development, and more!
Would you like to speak to one of ATCC’s representatives about a product or service? Make an appointment with us so we can discuss your needs.
Join our Fireside Chat
Speaker: Nilay Chakraborty, PhD, MBA, BioNexus Foundation Principal Scientist and Head of Cryobiology, ATCC
Track: Analytical Quality Track
Date: September 18, 2025
Time: 3:00 – 3:30 PM
Join Dr. Chakraborty for an engaging fireside chat as he delves into the science behind MicroQuant™ and its cutting-edge applications. Don’t miss this opportunity to explore the future of microbial quality control testing.
Explore our featured products for biologics production and safety testing
Browse our resources
MicroQuant™ - Precision in every pellet, trust in every test
Learn about our precisely quantitated microbial reference materials for streamlining microbial quality control testing.
More
Cell Lines for Enhanced Virus Production
ATCC used cutting-edge CRISPR/Cas9 gene-editing technology to develop STAT1 knockout or STAT1/BAX double knockout cell lines capable of producing high-titer viral stocks. Discover how these advanced biological models can be used in your vaccine and gene therapeutic development projects.
More
Mycoplasma Quality Control
ATCC has developed titered mycoplasma reference standards for comparing PCR and culture-based detection methods, and quantitative mycoplasma DNA certified reference materials for use as external controls in inclusivity/exclusivity testing and establishing limits of detection.
More
Viral Reference Materials
When evaluating a novel viral-vector-based gene therapy, accurately determining dose and potency is essential for patient safety. ATCC supports this need by providing internationally accepted viral reference materials that enable the standardization of quantification techniques between organizations.
More
Pharmaceutical Microbiology
ATCC provides pharmaceutical testing labs with the top-quality, fully characterized strains needed to maintain the highest levels of product integrity and reputation.
More
CAR-T Target Luciferase Reporter Cells
ATCC generated CAR-T Target Luciferase Reporter Cells lines that have high endogenous expression of clinically relevant cell surface tumor antigens, such as CD19, CD20, and HER2. These new immuno-oncology tools are comprised of both solid and liquid tumor cell lines that exhibit sensitive and stable luciferase reporter expression.
MoreContact us today!
We are ready to discuss your research needs and provide you with personalized care. Please complete our form to let us know how we can help, and we will start working on your needs right away.